International


COVID-19: Nasal Spray manufacture deal signed between Glenmark Pharmaceuticals and SaNOtize

COVID-19: Nasal Spray manufacture deal signed between Glenmark Pharmaceuticals and SaNOtize

Kathmandu, August 2. Glenmark Pharmaceuticals has signed a deal with Canadian company SaNOtize Research and Development Corp for the manufacture of nasal sprays that will be effective for the treatment against COVID-19. According to a statement by Glenmark Pharmaceuticals, they are planning to commercialize the spray and distribute it in India, Singapore, Malaysia, Hong Kong, Taiwan,

Pages: 1 92 93 94 95 96 215